Antiangiogenic VEGF isoform in inflammatory myopathies.

[inclusion body myositis]

To investigate expression of vascular endothelial growth factor (VEGF ) antiangiogenic isoform A-165 b on human muscle in idiopathic inflammatory myopathies (IIM ) and to compare distribution of angiogenic /antiangiogenic VEGFs , as isoforms shifts are described in other autoimmune disorders .We analyzed VEGF-A 165 b and VEGF-A by western blot and immunohistochemistry on skeletal muscle biopsies from 21 patients affected with IIM (polymyositis , dermatomyositis , and inclusion body myositis ) and 6 control muscle samples . TGF- β , a prominent VEGF inductor , was analogously evaluated . Intergroup differences of western blot bands density were statistically examined . Endomysial vascularization , inflammatory score , and muscle regeneration , as pathological parameters of IIM , were quantitatively determined and their levels were confronted with VEGF expression .V EGF-A 165 b was significantly upregulated in IIM , as well as TGF- β . VEGF-A was diffusely expressed on unaffected myofibers , whereas regenerating /atrophic myofibres strongly reacted for both VEGF-A isoforms . Most inflammatory cells and endomysial vessels expressed both isoforms . VEGF-A 165 b levels were in positive correlation to inflammatory score , endomysial vascularization , and TGF- β .Our findings indicate skeletal muscle expression of antiangiogenic VEGF-A 165 b and preferential upregulation in IIM , suggesting that modulation of VEGF-A isoforms may occur in myositides .

Diseases
Validation

Diseases presenting "growth factor" symptom

22q11.2 deletion syndrome

achondroplasia

adrenal incidentaloma

aniridia

cadasil

cholangiocarcinoma

coats disease

dedifferentiated liposarcoma

dentin dysplasia

dentinogenesis imperfecta

dystrophic epidermolysis bullosa

esophageal carcinoma

esophageal squamous cell carcinoma

hodgkin lymphoma, classical

holt-oram syndrome

inclusion body myositis

kallmann syndrome

krabbe disease

liposarcoma

lymphangioleiomyomatosis

oculocutaneous albinism

oral submucous fibrosis

pleomorphic liposarcoma

primary effusion lymphoma

primary hyperoxaluria type 1

severe combined immunodeficiency

systemic capillary leak syndrome

von hippel-lindau disease

wolf-hirschhorn syndrome

x-linked adrenoleukodystrophy

You can validate or delete this automatically detected symptom